Vistin Pharma ASA (VISTN) — Cash Flow-to-Debt Ratio
Vistin Pharma ASA (VISTN) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of Nkr-3.67 Million could theoretically repay 0% of its total liabilities (Nkr103.25 Million) in one year. See Vistin Pharma ASA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vistin Pharma ASA Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Vistin Pharma ASA across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Vistin Pharma ASA generate cash.
Annual Cash Flow-to-Debt Ratio for Vistin Pharma ASA (2016–2025)
Year-by-year debt coverage analysis for Vistin Pharma ASA. Check how high is Vistin Pharma ASA's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | Nkr78.04 Million | Nkr110.62 Million | ▼ -50.7% |
| 2024 | 1.43x | Nkr107.86 Million | Nkr75.42 Million | ▲ +27.3% |
| 2023 | 1.12x | Nkr90.59 Million | Nkr80.63 Million | ▲ +1797.2% |
| 2022 | -0.07x | Nkr-8.87 Million | Nkr133.95 Million | ▼ -127.7% |
| 2021 | 0.24x | Nkr13.68 Million | Nkr57.26 Million | ▲ +108.1% |
| 2020 | -2.94x | Nkr-145.73 Million | Nkr49.51 Million | ▼ -1511.0% |
| 2019 | 0.21x | Nkr18.93 Million | Nkr90.77 Million | ▲ +179.9% |
| 2018 | -0.26x | Nkr-39.48 Million | Nkr151.21 Million | ▼ -406.4% |
| 2017 | 0.09x | Nkr9.51 Million | Nkr111.59 Million | ▼ -85.3% |
| 2016 | 0.58x | Nkr53.84 Million | Nkr92.91 Million | — |